MUFG Americas’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-225
Closed -$1K 1042
2017
Q4
$1K Sell
225
-135
-38% -$510 ﹤0.01% 1036
2017
Q3
$1K Hold
360
﹤0.01% 1102
2017
Q2
$2K Hold
360
﹤0.01% 1084
2017
Q1
$2K Hold
360
﹤0.01% 1076
2016
Q4
$3K Sell
360
-375
-51% -$3.38K ﹤0.01% 994
2016
Q3
$7K Sell
735
-365
-33% -$4.92K ﹤0.01% 934
2016
Q2
$16K Buy
1,100
+900
+450% +$14K ﹤0.01% 752
2016
Q1
$3K Sell
200
-140
-41% -$2.05K ﹤0.01% 1082
2015
Q4
$7K Buy
+340
New +$5.25K ﹤0.01% 890

Other funds holding AGTC

MUFG Americas's AGTC Position: Q1 2018 in Review

MUFG Americas sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2018, closing a stake of 225 shares — an estimated $1K sold.

MUFG Americas first reported a position in AGTC in Q4 2015 and held it in 9 quarters. The position peaked at $16K in Q2 2016. 54 funds tracked by Wall St. Rank hold AGTC as of Q1 2018.

  • MUFG Americas reported no remaining Applied Genetic Technologies Corporation position as of Q1 2018 after selling out during the quarter.
  • MUFG Americas sold 225 Applied Genetic Technologies Corporation shares in Q1 2018, an estimated $1K.
  • MUFG Americas first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 9 quarters.
  • MUFG Americas's Applied Genetic Technologies Corporation position peaked at $16K in Q2 2016.
  • 54 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.